A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Stopped Business reasons, not related to safety or efficacy results.

Conditions

• Follicular Lymphoma (FL)
• Mantle Cell Lymphoma (MCL)
• Marginal Zone Lymphoma (MZL)
• Small Lymphocytic Lymphoma (SLL)
• Chronic Lymphocytic Leukemia (CLL)
• Diffuse Large B-cell Lymphoma (DLBCL)
• Acute Myeloid Leukemia (AML)

Interventions

• DRUG: voruciclib monotherapy
• DRUG: voruciclib and venetoclax

Sponsor

MEI Pharma, Inc.